Advertisement

Topics

The 5th International mRNA Health Conference to Showcase Advances in mRNA Cancer Therapy, Antibody Development and Vaccines

06:18 EDT 12 Sep 2017 | PR Newswire

TÜBINGEN, Germany and BERLIN, Sept. 12, 2017 /PRNewswire/ -- The 5th International mRNA Health Conference has unveiled the preliminary schedule for its two-day conference taking place on November 1-2 in Berlin, Germany. The conference will include talks and panel discussions focused on the evolution of groundbreaking mRNA research to next-generation pharmaceutical products targeting treatment opportunities in cancer, vaccination against infectious diseases, as well as antibody development and protein replacement therapy. The event will be highlighted by a keynote address from extreme mountaineer Reinhold Messner.

Early-bird registration for the 5th International mRNA Health Conference ends on September 15, 2017. To register and benefit from the discounted entry fee, please visit http://mrna-conference.com/register/.

The 5th International mRNA Health Conference

Date:           

November 1-2, 2017

Place:           

Berlin, Germany

Location:      

Sofitel Berlin Kurfürstendamm, Augsburger Strasse 41, 10789 Berlin, Germany

Website:       

www.mrna-conference.com

Program:        

The Conference, organized by BioNTech, CureVac and Moderna, will provide a comprehensive program around the medical use of Messenger RNA. Hundreds of world renowned innovators, scientists, academia and pharmaceutical delegates are expected to attend the conference as mRNA therapeutic technology evolves from scientific concept to medical application. Approximately 25 speakers will present on preclinical and clinical development in the fields of oncology, infectious diseases and molecular therapies as well as mRNA delivery, design and product development. Additionally, a poster session will provide research groups and company representatives the opportunity to showcase their data to attendees.

Registration:   

Register by September 15th and benefit from early bird prices       
http://mrna-conference.com/register/

Contact:       

organization@mrna-conference.com

Media Contacts

Verena Lauterbach, Senior Manager Communications
CureVac AG, Tübingen, Germany
T: +49 (0) 7071 9883 1756
verena.lauterbach@curevac.com

Jason Rando, EVP & COO
Tiberend Strategic Advisors, New York
+1 212 375 2665
jrando@tiberend.com

View original content with multimedia:http://www.prnewswire.com/news-releases/the-5th-international-mrna-health-conference-to-showcase-advances-in-mrna-cancer-therapy-antibody-development-and-vaccines-300517807.html

SOURCE CureVac

NEXT ARTICLE

More From BioPortfolio on "The 5th International mRNA Health Conference to Showcase Advances in mRNA Cancer Therapy, Antibody Development and Vaccines"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...